Search...
Cara Therapeutics initiates 1-for-3 reverse stock split amid merger with Tvardi Therapeutics, effective per Board approval.
In Stamford, Connecticut on April 14, 2025, Cara Therapeutics, Inc. disclosed a major decision. The company, listed as CARA on Nasdaq, revealed that its Board of Directors has greenlit a 1-for-3 reverse stock split for its current common stock shares.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments